455 related articles for article (PubMed ID: 9509964)
1. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
2. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor has contrasting effects in combination with 5-fluorouracil or total-body irradiation on frequencies of different hemopoietic cell subsets and engraftment of transplanted bone marrow.
Down JD; de Haan G; Dillingh JH; Dontje B; Nijhof W
Radiat Res; 1997 Jun; 147(6):680-5. PubMed ID: 9189165
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
5. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
7. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
[TBL] [Abstract][Full Text] [Related]
8. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
9. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
Robinson S; van Os R; Sheridan T; Mauch P
Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor prior to nonmyeloablative irradiation decreases murine host hematopoietic stem cell function and increases engraftment of donor marrow cells.
Barese C; Pech N; Dirscherl S; Meyers JL; Sinn AL; Yoder MC; Goebel WS; Dinauer MC
Stem Cells; 2007 Jun; 25(6):1578-85. PubMed ID: 17347493
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose-fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model.
van Os R; Thames HD; Konings AW; Down JD
Radiat Res; 1993 Oct; 136(1):118-25. PubMed ID: 8210327
[TBL] [Abstract][Full Text] [Related]
12. Studies on the hyperthermic sensitivity of the murine hematopoietic stem cell compartment. II. Heat effect on donor stem cells with long-term repopulating ability.
Wierenga PK; Konings AW; Down JD
Exp Hematol; 1995 Feb; 23(2):108-11. PubMed ID: 7828667
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
14. Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.
Down JD; Boudewijn A; Dillingh JH; Fox BW; Ploemacher RE
Br J Cancer; 1994 Oct; 70(4):611-6. PubMed ID: 7917905
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
Koh CY; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
[TBL] [Abstract][Full Text] [Related]
16. Compromising effect of low dose-rate total body irradiation on allogeneic bone marrow engraftment.
van Os R; Konings AW; Down JD
Int J Radiat Biol; 1993 Dec; 64(6):761-70. PubMed ID: 7903344
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model.
van Os R; Sheridan TM; Robinson S; Drukteinis D; Ferrara JL; Mauch PM
Stem Cells; 2001; 19(1):80-7. PubMed ID: 11209093
[TBL] [Abstract][Full Text] [Related]
18. The role of recombinant cytokines and other immunomodulators on engraftment following allogeneic bone marrow transplantation in mice.
Bieder A; Weiss L; Slavin S
Bone Marrow Transplant; 1992 Jun; 9(6):421-6. PubMed ID: 1628125
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
20. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD
Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
